GlassScriptPhysician profile
Robinder Paul Singh
NPI 1891957148
$5,707.91
in general payments reported to CMS, 2019-2025
25 companies · $3,679 in 2025
The $3,679 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $113 · 2021: $122 · 2022: $225 · 2023: $880 · 2024: $580 · 2025: $3,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,812 · Food and Beverage: $2,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,811.67 |
| Food and Beverage | $2,327.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $3,059.64 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $473.58 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Axogen | $437.46 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Allergan, INC. | $297.95 | 2019-2022 | |
| Polynovo North America LLC | $230.24 | 2025 | Novosorb Btm |
| Mentor Worldwide LLC | $148.76 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $135.57 | 2025 | |
| Integra Lifesciences Corporation | $133.69 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bard Peripheral Vascular, INC. | $132.52 | 2023 | Crosser Iq |
| Mimedx Group, INC. | $107.46 | 2024-2025 | |
| Davol INC. | $76.90 | 2025 | Phasix Mesh |
| Apyx Medical Corporation | $73.53 | 2019-2020 | |
| Ethicon US, LLC | $56.71 | 2022-2024 | Dermabond, Stratafix |
| Organogenesis INC. | $48.45 | 2022-2024 | |
| Stryker Corporation | $42.39 | 2025 | Spy-Phi System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $39.54 | 2024-2025 | |
| Sientra, INC. | $36.36 | 2022 | |
| Checkpoint Surgical, INC | $34.67 | 2023 | Checkpoint Stimulators |
| Galderma Laboratories, L.P. | $27.15 | 2020-2022 | |
| Dilon Technologies, INC. | $23.92 | 2024 | Hemoblast Bellows |
| Acumed LLC | $23.49 | 2023 | Inframe Implant, Osteomed, Acumed |
| Trevena, INC. | $19.65 | 2021 | |
| Chiesi USA, INC. | $17.43 | 2024 | Cleviprex |
| Cumberland Pharmaceuticals, INC. | $16.49 | 2023 | Caldolor |
| Smith+Nephew, INC. | $14.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.